Texas Oncology - San Antonio Medical Center

San Antonio, TX

Sorting 2 by

Accepting patients

SUCCESSOR-1

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared to Pomalidomide, Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
  • CELMoD
  • Randomization
  • Phase 3

Accepting patients

Teclistamab

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
  • Bispecific Antibody
  • BCMA
  • Phase 2